CervomedCRVO
13F holders, Q4 2024 (December 31)49holders −1
12new positions
16sold out
2famous investors
$2.33avg. 13F price*
At the end of Q4 2024, 49 institutions reported holding Cervomed Inc. (CRVO) in their 13F filings, down 1 from Q3 2024. 12 opened new positions and 16 sold out. The largest holders were Vanguard Group Inc. ($897K), BlackRock, Inc. ($759K) and State Street Corp. ($272K). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cervomed Inc.
- CUSIP
- 15713L109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $602K |
| Exits | 16 | $33.6M |
All 13F filers, Q3 2024 → Q4 2024: 368,430 shares bought and 2,388,589 shares sold, net −2,020,159 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 49 holders
| Vanguard Group Inc. | 0.00% | Reduce -4.2% | 383,487 | $897K |
| BlackRock, Inc. | 0.00% | Add +1.7% | 324,308 | $759K |
| State Street Corp. | 0.00% | Add +11.3% | 116,256 | $272K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.1% | 114,835 | $269K |
| Woodline Partners LP | 0.00% | New | 74,852 | $175K |
| Perigon Wealth Management, LLC | 0.00% | New | 62,729 | $132K |
| Northern Trust Corp. | 0.00% | Reduce -5.2% | 50,908 | $119K |
| Morgan Stanley | 0.00% | Add +12.3% | 50,628 | $118K |
| UBS Group AG | 0.00% | Add +1609.3% | 43,365 | $101K |
| Nuveen Asset Management, LLC | 0.00% | Add +113.6% | 41,569 | $97K |
| Qube Research & Technologies Ltd | 0.00% | New | 28,021 | $66K |
| Cornerstone Wealth Management, LLC | 0.00% | New | 20,650 | $48K |
| Millennium Management | 0.00% | Add +18.6% | 18,463 | $43K |
| JPMorgan Chase & Co. | 0.00% | Add +251.8% | 14,464 | $34K |
| BNP Paribas Financial Markets | 0.00% | New | 13,773 | $32K |
| Goldman Sachs Group Inc. | 0.00% | New | 13,750 | $32K |
| Mariner, LLC | 0.00% | New | 12,937 | $30K |
| HRT Financial LP | 0.00% | New | 12,987 | $30K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 12,722 | $30K |
| DRW Securities, LLC | 0.00% | New | 12,708 | $30K |
| Virtu Financial LLC | 0.00% | New | 11,224 | $26K |
| Citadel Advisors | 0.00% | Reduce -13.5% | 10,811 | $25K |
| Barclays PLC | 0.00% | Add +10.4% | 8,557 | $20K |
| Bank of America Corp. | 0.00% | Add +35.4% | 5,260 | $12K |
| Citigroup Inc. | 0.00% | Add +11.0% | 4,324 | $10K |
| Rhumbline Advisers | 0.00% | Reduce -5.5% | 4,304 | $10K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +5.1% | 3,158 | $7K |
| Corebridge Financial, Inc. | 0.00% | Reduce -7.0% | 2,685 | $6K |
| Wells Fargo & Company | 0.00% | Add +51.6% | 2,523 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +340.6% | 2,454 | $6K |
| Legal & General Group Plc | 0.00% | No change | 2,114 | $5K |
| Hoey Investments, Inc. | 0.00% | No change | 1,080 | $3K |
| FMR LLC | 0.00% | Reduce -72.8% | 1,052 | $2K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 529 | $1K |
| New York State Common Retirement Fund | 0.00% | No change | 400 | $936 |
| Osaic Holdings, Inc. | 0.00% | No change | 395 | $924 |
| California State Teachers Retirement System | 0.00% | No change | 391 | $915 |
| Russell Investments Group, Ltd. | 0.00% | Reduce -80.8% | 229 | $536 |
| SBI Securities Co., Ltd. | 0.00% | — | 155 | $363 |
| Aventura Private Wealth, LLC | 0.00% | — | 68 | $159 |
| Nisa Investment Advisors, LLC | 0.00% | New | 45 | $105 |
| Sterling Capital Management LLC | 0.00% | No change | 6 | $14 |
| Medallion Wealth Advisors, LLC | 0.00% | — | 2 | $5 |
| Avior Wealth Management, LLC | 0.00% | No change | 2 | $4 |
| Danske Bank A/S | 0.00% | No change | 1 | $2 |
| Amalgamated Bank | 0.00% | No change | 187 | $0 |
| Royal Bank of Canada | 0.00% | Reduce -72.2% | 213 | $0 |
| Cwm, LLC | 0.00% | Reduce -100.0% | 24 | $0 |
| Covestor Ltd | 0.00% | New | 190 | $0 |
"% of holder's portfolio" is CRVO's weight in each manager's 13F, not the share of Cervomed Inc. the manager owns.